Aldeyra Therapeutics (ALDX) Preferred Dividend Payments (2013 - 2014)
Aldeyra Therapeutics' (ALDX) quarterly Preferred Dividend Payments came in at -$3.7 million in Q4 2014, down 1134.89% YoY from $359504.0 in Q4 2013, and down 1842.12% on a QoQ basis from -$191568.0 in Q3 2014.
Aldeyra Therapeutics (ALDX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 2 years of Preferred Dividend Payments data on file, last reported at -$3.7 million in Q4 2014.
- Quarterly Preferred Dividend Payments fell 1134.89% year-over-year to -$3.7 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $333082.0 (down 96.25% YoY) and the FY2014 annual result came in at $333082.0, down 59.51% from the prior year.
- Preferred Dividend Payments retreated to -$3.7 million in Q4 2014, from -$191568.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $8.2 million in Q3 2013 to a low of -$3.7 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Aldeyra Therapeutics | 91.08 Mn | 91.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -3.72 Mn |
| Sep 30, 2014 | -191,568.00 |
| Jun 30, 2014 | 4.05 Mn |
| Mar 31, 2014 | 191,568.00 |
| Dec 31, 2013 | 359,504.00 |
| Sep 30, 2013 | 8.24 Mn |
| Jun 30, 2013 | 150,095.00 |
| Mar 31, 2013 | 123,159.00 |